Microbot Medical stock holds near 1.49 USD as losses stay deep

Published on 09/01/2026 at 21:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Microbot Medical stock traded at 1.49 USD on September 1, 2026, with a 100.1 million USD market cap. The latest reported quarter showed 8.64 million USD revenue and a 5.53 million USD loss.

MBOT, US5950101098, Illustration mit AI erstellt.

Microbot Medical Inc. (US5950101098) traded at 1.49 USD on September 1, 2026, with a market value of 100.1 million USD. Yahoo Finance showed the stock up 0.68 percent on the day, while the 52-week range ran from 1.24 USD to 3.59 USD.

Quarterly loss still outweighs sales

The latest reported quarter cited in Yahoo Finance showed 8.64 million USD revenue and a 5.53 million USD loss. That is a wide gap for a company with a 30.07 million USD trailing revenue base and a diluted EPS of minus 0.24 USD.

For investors, the comparison is plain: revenue is still small, while the loss margin remains severe. Yahoo Finance also showed a profit margin of minus 74.24 percent and total cash of 10.49 million USD.

Analysts still see upside

Yahoo Finance listed an average analyst price target of 3.00 USD and a latest TD Cowen action on August 12, 2026, that kept a Buy rating while lowering the target from 5 USD to 3 USD. The current quote of 1.49 USD still sits well below that level.

The stock also showed a 1-year return of minus 50.00 percent and a YTD move of minus 37.39 percent in the same data set. That mix leaves the chart weak even before any fresh company catalyst enters the picture.

Go deeper

Why the latest quarter matters

Microbot Medical's revenue base, cash position and analyst target give the stock its current frame after the latest reported quarter.

Microbot Medical system line

Microbot Medical develops robotic and minimally invasive technologies for endovascular procedures, a niche that keeps product progress central to the story. In the Yahoo Finance company profile, the business is classified in Medical Devices, which matches the medical technology backdrop behind the shares.

1.49 USD stays the level

Microbot Medical stock last traded at 1.49 USD on September 1, 2026, alongside an intraday market cap of 100.1 million USD. The 52-week band from 1.24 USD to 3.59 USD shows how far the shares can still move on any renewed operating update.